Statistics for Veracyte (id:6442 VCYT)
Valuation metrics
Market cap
3.17B
Enterprise value
2.91B
Trailing P/E (ttm)
-40.09
Forward P/E
102.22
PEG ratio
102.22
Price/Sales (ttm)
7.45
Price/Book (mrq)
2.69
Enterprise Value/Revenue
6.85
Enterprise Value/EBITDA
66.22
Overview
Shares outstanding
77.50M
Float
77.15M
Shares short
2.97M
% Held by insiders
5.00%
% Held by institutions
1.04%
Average volume (10 days)
806.52K
Average volume (90 days)
Price summary
52-Week low
18.61
52-Week high
46.00
52-Week change
30.20%
Beta
1.67
50-Day moving average
38.32
200-Day moving average
28.16
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-2.18%
Operating margin
10.53%
Operational effectiveness
Return on assets
1.07%
Return on equity
3.00%
Income statement
Revenue (ttm)
5.64
Revenue per share (ttm)
5.64
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
248.15M
EBITDA
45.91M
Net income to common (ttm)
-9,268,000.00
Diluted EPS (ttm)
3.00
Quarterly earnings growth (yoy)
28.58%
Balance sheet
Total cash (mrq)
274.08M
Total cash per share (mrq)
3.54
Total debt (mrq)
19.79M
Total Debt/Equity (mrq)
1.68
Current ratio (mrq)
507.50%
Book value per share (mrq)
15.18
Cash flow
Cash flow statement
66.12M
Levered free cash flow (LFCF)
57.26M